Osmoregulation of natriuretic peptide receptors in bromoethylamine-treated rat kidney.
Extracellular osmolarity is known as an important factor for the regulation of natriuretic peptide receptors (NPRs). We investigated the intra-renal osmoregulation of NPRs using renal medullectomized rats with bromoethylamine hydrobromide (BEA, 200mg/kg). The administration of BEA caused the decreased food intake and body weight. Water intake was decreased on the first day and then increased from the second day. Urine volume was persistently increased from the first day and free water clearance was also increased from the second day. Urinary excretions of sodium and potassium were decreased on the second day and then recovered to control level. Plasma levels of atrial natriuretic peptide (ANP) and Dendroaspis natriuretic peptide (DNP) in BEA-treated rats were not different from control rats. The inactive renin was increased. The maximum binding capacities of (125)I-ANP as well as (125)I-DNP decreased in glomeruli and medulla of BEA-treated rat kidneys but the binding affinity was not changed. In renal cortex, the gene expressions of ANP, NPR-A, and NPR-B were not changed but that of NPR-C decreased. In renal medulla, the gene expressions of NPR-A, -B, and -C decreased without change in ANP mRNA. Both renal medullary osmolarity and sodium concentration by BEA treatment were lower than those in control kidney. The cGMP concentrations in renal medulla and urine in BEA-treated rats were higher than those in control rats. These results suggest that the increased cGMP production may be partly involved in the decrease in NPRs mRNA expression and their binding capacities by BEA-induced medullectomy.
Yuan
Kuichang
K
Department of Cardiology, Yanbian University Hospital, Yanji, Jilin Province, China.
Jin
Xuanshun
X
Gao
Shan
S
Shah
Amin
A
Kim
Sun Young
SY
Kim
Sung Zoo
SZ
Kim
Suhn Hee
SH
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood / Q000235:genetics; D001665:Binding Sites; D001835:Body Weight / Q000187:drug effects; D006152:Cyclic GMP / Q000096:biosynthesis / Q000652:urine; D004435:Eating / Q000187:drug effects; D004546:Elapid Venoms / Q000097:blood / Q000235:genetics; D005021:Ethylamines / Q000494:pharmacology*; D036341:Intercellular Signaling Peptides and Proteins; D007668:Kidney / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010455:Peptides / Q000097:blood / Q000235:genetics; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D017461:Receptors, Atrial Natriuretic Factor / Q000187:drug effects / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014882:Water-Electrolyte Balance
C075597:Dendroaspis natriuretic peptide; D004546:Elapid Venoms; D005021:Ethylamines; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; D012333:RNA, Messenger; C004504:2-bromoethylamine; D009320:Atrial Natriuretic Factor; D017461:Receptors, Atrial Natriuretic Factor; D006152:Cyclic GMP